The former CEO of chemical industry giant Perstorp Martin Lundin has been appointed Chairman of the Board for Umeå-based Spinchem AB. “Spinchem combines fascinating cutting-edge technology with talented employees while operating in an exciting market”, says Martin Lundin.
Umeå Biotech Incubator (UBI) is ranked as one of the best Life science incubators in Europa. Now UBI launches an international incubator program. “If you strive to be one of the world's best incubators you must have the whole world as your marketplace”, says Jennie Ekbeck, CEO of UBI.
The Umeå company Xerum has received a new national assignment to measure the presence of antibodies against SARS-CoV-2, the virus that causes covid-19 in Sweden. Xerum has performed and analyzed around 10 000 tests during the pandemic.
Mucocort AB is a Swedish company that has developed a unique self-absorbing pain relief patch for people suffering from recurrent mouth ulcers - aphthous stomatitis. The company has now signed a production agreement with medical technology company Aurena Laboratories AB, which also becomes a stakeholder in Mucocort.
The Umeå-based biopharmaceutical company Omnio AB, focusing on wound healing, has received a capital injection of 1.5 million euros from its shareholders, which will be used for ongoing development work and to begin creating a blueprint for manufacturing.
Tomas Ruuth is the new Head of PR and Communications at Umeå Biotech Incubator.
The Umeå based company Nordic Biomarker has won the award The Export Success of the Year in Sweden.
Umeå-based Lipum will reach an important milestone in its history this year as clinical trials begin on its antibody to treat inflammatory diseases. No less than 17 consultants are now involved in the drug’s development.
Swedish biotech company Agrisera has nearly doubled its workforce in the past two years, having recently moved to new and larger premises. “Demand for our products and services is increasing rapidly. We are in a growth phase and will seek additional talent in the future”, says Erika Gelfgren, CEO of Agrisera.
Umeå Biotech Incubator (UBI) is arranging a recruitment day with life science companies this May - and already 19 companies have signed up to take part. “We want students to get in touch with us. Recruitment opportunities are everything for life science companies”, says Jennie Ekbeck, CEO of Umeå Biotech Incubator.
The life science industry in the Umeå region is on track to triple its turnover and double the number of people it employs by 2030. To help it reach this target, the Swedish Agency for Economic and Regional Growth has awarded Umeå Biotech Incubator (UBI) a grant of SEK 9.5 million.
Umeå-based QureTech Bio AB receives support from the Swedish Research Council's major investment ENABLE-2, which in collaboration with Vinnova gives small and medium-sized companies access to the ENABLE-2 platform to continue development of new antibiotics.
Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.
Tvistevägen 48C
907 36 Umeå
Sweden